Business Description
Torrent Pharmaceuticals Ltd
NAICS : 325412
ISIN : US89141F1093
Share Class Description:
TQRRY: ADRCompare
Compare
Traded in other countries / regions
TORNTPHARM.India IPO Date
2015-01-05Description
Torrent Pharmaceuticals Ltd is a drug manufacturing company with a focus on the cardiovascular, central nervous system, and gastrointestinal therapeutic areas. It operates through the Generic Formulation Business segment. Geographically, the business activities are carried out across Indian and International markets. Maximum revenue for the company is generated from its operations in India.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.25 | |||||
| Equity-to-Asset | 0.46 | |||||
| Debt-to-Equity | 0.59 | |||||
| Debt-to-EBITDA | 1.12 | |||||
| Interest Coverage | 8.25 | |||||
| Piotroski F-Score | 8/9 | |||||
| Altman Z-Score | 10.26 | |||||
| Beneish M-Score | -3.01 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 10.2 | |||||
| 3-Year EBITDA Growth Rate | 11.4 | |||||
| 3-Year EPS without NRI Growth Rate | 8.7 | |||||
| 3-Year FCF Growth Rate | 19.3 | |||||
| 3-Year Book Growth Rate | 5.5 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 25.72 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 12.74 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.03 | |||||
| Quick Ratio | 0.61 | |||||
| Cash Ratio | 0.19 | |||||
| Days Inventory | 289.02 | |||||
| Days Sales Outstanding | 62.24 | |||||
| Days Payable | 233.26 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Dividend Growth Rate | 44.2 | |||||
| Shareholder Yield % | 1.21 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 73.85 | |||||
| Operating Margin % | 24.74 | |||||
| Net Margin % | 16.03 | |||||
| ROE % | 26.35 | |||||
| ROA % | 11.62 | |||||
| ROIC % | 14.81 | |||||
| 3-Year ROIIC % | 25.32 | |||||
| ROC (Joel Greenblatt) % | 54.87 | |||||
| ROCE % | 28.94 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 67.32 | |||||
| Forward PE Ratio | 53.82 | |||||
| PE Ratio without NRI | 69.97 | |||||
| Shiller PE Ratio | 86 | |||||
| Price-to-Owner-Earnings | 43.77 | |||||
| PEG Ratio | 5.51 | |||||
| PS Ratio | 10.79 | |||||
| PB Ratio | 17.04 | |||||
| Price-to-Free-Cash-Flow | 41.23 | |||||
| Price-to-Operating-Cash-Flow | 35.77 | |||||
| EV-to-EBIT | 42.77 | |||||
| EV-to-EBITDA | 33.26 | |||||
| EV-to-Revenue | 11.07 | |||||
| EV-to-FCF | 42.3 | |||||
| Earnings Yield (Greenblatt) % | 2.34 | |||||
| FCF Yield % | 2.43 | |||||
| Forward Rate of Return (Yacktman) % | 14.15 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with GREY:TQRRY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Torrent Pharmaceuticals Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | 0.91 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR ($) | 0 | ||
| 20-Day SMA ($) | 0 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range ($) | 0 - 0 | ||
| Shares Outstanding (Mil) | 169.22 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Torrent Pharmaceuticals Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Torrent Pharmaceuticals Ltd Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Torrent Pharmaceuticals Ltd Frequently Asked Questions
What is Torrent Pharmaceuticals Ltd(TQRRY)'s stock price today?
The current price of TQRRY is $0.00. The 52 week high of TQRRY is $0.00 and 52 week low is $0.00.
When is next earnings date of Torrent Pharmaceuticals Ltd(TQRRY)?
The next earnings date of Torrent Pharmaceuticals Ltd(TQRRY) is 2024-10-25 Est..
Does Torrent Pharmaceuticals Ltd(TQRRY) pay dividends? If so, how much?
Torrent Pharmaceuticals Ltd(TQRRY) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers